Merck & Co. Inc. Stock Rises 3.8%, Outperforms Peers
Dow Jones2026/08/25 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Merck & Co. Inc. rallied 3.8% to $156.45 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.3% to 7,677.28 and the Dow Jones Industrial Average rising 0.3% to 53,577.40.
Merck & Co. Inc. hit a new 52-week high, surpassing its previous peak of $154.49, which the company achieved on August 21st.
The stock outperformed some of its peers, as Johnson & Johnson rose 0.5% to $273.14, Pfizer Inc. rose 2.1% to $28.57, and Eli Lilly & Co. fell 1.06% to $1,233.66.
Trading volume totaled 13.7 million, compared to the 50-day average of 10.8 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 25, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Gurman predicts iPhone Duo: The first foldable may set industry standards, Apple (AAPL.US) foldable could trigger a decade-long upgrade cycle
Renowned financial journalist Mark Gurman stated that Apple’s first foldable iPhone has the potential to elevate the still-experimental foldable phone category to an industry standard. He noted that this device, called the iPhone Duo, is one of Apple’s most influential products, ranking just behind the iMac, iPod, iPad, and Apple Watch.
Element Fleet drops bid for FleetPartners, exits sale process
Anchoring to Nasdaq! Anthropic races toward a record-breaking IPO with fundraising scale targeting SpaceX
Sources indicate that Anthropic PBC has chosen Nasdaq as its listing venue, and the potential IPO is expected to set a historic record.
10-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
